Recovery Following Lateral Medullary Infarction
Neurol 50:1418-1422, Nelles,G.,et al, 1998
Different Predictors of Neurolgoical Worsening in Different Causes of Stroke
Arch Neurol 55:481-486, Yamamoto,H.,et al, 1998
Surgery for Prevention of Stroke
ECST Organization, Lancet 351:1372-1373, 1379998., , 1998
Blood Pressure Control and Recurrence of Hypertensive Brain Hemorrhage
Stroke 29:1806-1809, Arakawa,S.,et al, 1998
Quality of Life in Patients and Partners After Aneurysmal Subarachnoid Hemorrhage
Stroke 29:798-804, Hopp,J.W.,et al, 1998
Prognosis of Patients with Symptomatic Vertebral or Basilar Artery Stenosis
WASID Study Group, Stroke 29:1389-13921998., , 1998
Giant Cell Arteritis and Vernet's Syndrome
Neurol 50:1862-1864, Gout,O.,et al, 1998
Postural Vision Loss in Giant Cell Arteritis
J Neuro-Ophthalmol 18:124-126, Diego,M.&Margo,C.E., 1998
Occult Giant Cell Arteritis:Ocular Manifestations
Am J Ophthalmol 125:521-526, Hayreh,S.S.,et al, 1998
Aspirin Use and Incident Stroke in the Cardiovascular Health Study
Stroke 29:887-894, 8851998., Kronmal,R.A.,et al, 1998
Clopidogrel for Reduction of Atherosclerotic Events
The Medical Letter 40:59-60, , 1998
Prevent of a 1st Stroke by Transfusions in Children/Sickle Cell Anemia & Abnorm Results on Transcr Doppler Ultrasonog
NEJM 339:5-11, Adams,R.J.,et al, 1998
Cost-Effectiveness of Anticoagulation in Nonrheumatic A Fib in the Primary Prevention of Ischemic Stroke
Stroke 29:1827-1832, Lightowlers,S.&McGuire,A., 1998
Fixed Minidose Warfarin & Aspirin Alone & in Comb vs Adjusted-Dose Warfarin for Stroke Prevent in Atrial Fib
Arch Int Med 158:1513-1521, 14871998., Gullov,A.L.,et al, 1998
Pts with Nonvalvular Fib at Low Risk of Stroke During Trtm with Aspirin
Stroke Prevent in A Fib, SPAF III Cmte for Stroke Prevent, JAMA 279:1273-1277998., , 1998
Mechanisms of Second and Further Strokes
JNNP 64:771-776, 7161998., Yamamoto,H.&Bogousslavsky,J., 1998
Transesoph Echocardiogr Correl of Thromboembolism in High-Risk Pts with Nonvalv Atrial Fib
Ann Int Med 128:639-647, 6851998., Chan,K.L.,et al, 1998
Consumption of Fruit and Wine and the Decline in Cerebrovascular Disease Mortality in Spain (1975-1993)
Stroke 29:1556-1561, Artalejo,F.R.,et al, 1998
Ash-Leaf Spots in Tuberous Sclerosis
NEJM 338:1887, Kurlemann,G.&Schuierer,G., 1998
An Open-Label Trial of Gabapentin Treatment of Paroxysmal Symptoms in Multiple Sclerosis Patients
Neurol 51:609-611, Solaro,C.,et al, 1998
Gabapentin Relieves Trigeminal Neuralgia in Multiple Sclerosis Patients
Neurol 51:611-614, Khan,O.A., 1998
Rate of Pregnancy-Related Relapse in Multiple Sclerosis
NEJM 339:285-291, 3391998., Confavreux,C.,et al, 1998
Spinal Cord Atrophy and Disability in MS
Neurol 51:234-238, Stevenson,V.L.,et al, 1998
Synergistic Immunomod Effects of Interferon-Beta1b & Phosphodiesterase Inhib Pentoxifylline in Pts with Relapsing-Remit MS
Ann Neurol 44:27-34, 71998., Weber,F.,et al, 1998
Effects of Copolymer-1 on Serial Gadolinium-Enhanced MRI in Relapsing Remitting Multiple Sclerosis
Neurol 50:1127-1133, Mancardi,G.L.,et al, 1998
Intravenous Immunoglobulin G Reduces MRI Activity in Relapsing Multiple Sclerosis
Neurol 50:1273-1281, Sorensen,P.S.,et al, 1998
Tardive Dyskinesia:Diagnosis, Pathogenesis, and Management
The Neurologist 4:180-187, Trugman,J.M., 1998
Double-Blind, Randomized, Placebo-Controlled Study of Oral, High-Dose Methylprednisolone in Attacks of MS
Neurol 51:529-534, Sellebjerg,F.,et al, 1998
Randomized Trial Comparing Two Different High Doses of Methylprednisolone in MS, A Clinical and MRI Study
Neurol 50:1833-1836, Oliveri,R.L.,et al, 1998
Neuroradiologic Findings in Marinesco-Sjogren Syndrome
AJNR 19:281-283, Georgy,B.A.,et al, 1998
Dural Sinus Thrombosis:Findings on CT and MR Imaging and Diagnostic Pitfalls
AJR 170:777-783, Provenzale,J.M.,et al, 1998
An Algorithm (Decision Tree) for the Management of Parkinson's Disease:Trtm Guidelines
Neurol 50:S1-S57, Olanow,C.W.&Koller,W.C., 1998
Stereotactic pallidotomy for Trtm of Parkinson's Disease, Efficacy & Adverse Effects at 6 Mo in 26 Pts
Neurol 50:434-438, Shannon,K.M.,et al, 1998
Assessment of Motor Function After Stereotactic Pallidotomy
Neurol 50:266-270, Ondo,W.G.,et al, 1998
Clinicopath Conf
Dementia with Lewy Bodies, Anaplastic Astrocytoma of Right Insular Region, Case 7-1998, NEJM 338:603, 61098., 1998
Numb Chin Syndrome as the Initial Manifestation of HIV Infection
Neurol 50:511-512, Benito-Leon,J.,et al, 1998
Lhermitte's Sign Following Chemotherapy with Docetaxel
Neurol 50:563-564, van den Bent,M.J.,et al, 1998
Multiple Sclerosis Associated with Chlamydia Pneumoniae Infection of the CNS
Neurol 50:571-572, Sriram,S.,et al, 1998
Paraneoplastic Necrotizing Myopathy, Clinical and Pathologic Features
Neurol 50:764-767, Levin,M.I.,et al, 1998
White Matter Disease Induced by High-Dose Chemotherapy:MR Imaging & Proton Spectroscopy
AJNR 19:217-221, Brown,M.S.,et al, 1998
Neurology and the Blood:Haematological Abnormalities in Ischaemic Stroke
JNNP 64:150-159, Markus,H.S.&Hambley,H., 1998
Paraneoplastic Demyelinating Disorder in the Brain of a Patient with Seminoma
J Comput Assist Tomogr 22:136-138, Wong,K.,et al, 1998
Evaluation and Management of Intracranial Mass Lesions in AIDS
Rpt of Quality Stnds Subcomm of the AAN, Neurol 50:21-261998., , 1998
Human Herpesvirus 8 DNA in CNS Lymphomas from Patients With and Without AIDS
Neurol 50:335-340, 3221998., Corboy,J.R.,et al, 1998
Optic Neuritis, Prognosis for Multiple Sclerosis from MRI, CSF, and HLA Findings
Neurol 50:708-714, Soderstrom,M.,et al, 1998
Optic Neuritis in African Americans
Arch Neurol 55:186-192, Phillips,P.H.,et al, 1998
Extended Use of Glatiramer Acetate (Copaxone) Is Well Tol & Maint Its Clin Effect on MS Relapse Rate & Degree of Disabil
Neurol 50:701-708, Johnson,K.P.,et al, 1998
Intravenous Immunoglobulin Treatment in Multiple Sclerosis, Effect on Relapses
Neurol 50:398-402, Achiron,A.,et al, 1998
Progressive Atrophy of Cerebellum & Brainstem, Age & Size of Expanded CAG Repeats in the MJDI Gene in Machado-Joseph Dis
Ann Neurol 43:288-296, Onokera,O.,et al, 1998
Risk of Cerebral Sinus Thrombosis in Oral Contraceptive Users Who Are Carriers of Hered Prothrombotic Cond
BMJ 316:589-592, deBruijn,S.F.T.M.,et al, 1998